GC
ABVX

Guggenheim Capital’s Abivax ABVX Stock Holding History

Guggenheim Capital’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.79M Sell
25,074
-12
-0% -$1.42K 0.02% 605
2025
Q4 		$3.38M Buy
25,086
+7,828
+45% +$854K 0.02% 534
2025
Q3 		$1.47M Buy
17,258
+1,161
+7% +$71.2K 0.01% 788
2025
Q2 		$123K Buy
16,097
+2,305
+17% +$15K ﹤0.01% 1550
2025
Q1 		$86.2K Buy
13,792
+1,280
+10% +$8.66K ﹤0.01% 1612
2024
Q4 		$91.6K Buy
+12,512
New +$115K ﹤0.01% 1662

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return